Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEUPROLIDE ACETATE
- Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
- GnRH-a on Angiogenesis of Endometriosis
- Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers
- Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
- A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
- A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty
- RElugolix VErsus LeUprolide Cardiac Trial
- Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
- Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
- Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer
- Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
- Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
- Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
- Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
- Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study
- Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
- Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
- A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
- Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Using PET/CT Imaging
- Study of Abiraterone Acetate, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
- Neurobiology of Bulimia Nervosa
- A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
- PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
- Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
- Elagolix for Fertility Enhancement Clinical Trial
- REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
- A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
- A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
- GnRH Agonist at Embryo Transfer: IVF Outcomes
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
- Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
- Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
- Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
- Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
- A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
- A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
- Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Menopausal Sleep Fragmentation and Body Fat Gain
- A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
- A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
- A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
- Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
- Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
- Regulation of Cervical Mucus Secretion
- Brown Adipose Tissue Activity in Pre- and Postmenopausal Women
- Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
- AASUR in High Risk Prostate Cancer
- Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
- Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)
- A Study of Definitive Therapy to Treat Prostate Cancer
- NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
- Management of Castration-Resistant Prostate Cancer With Oligometastases
- IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure
- A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
- Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases
- Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)
- Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer
- PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
- Discovery Stage IND EXEMPT Clinical Study About ABIRATERONE ACETATE and Single Nucleotide Polymorphisms
- Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
- Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
- Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
- High-Dose Brachytherapy in Treating Patients With Prostate Cancer
- Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
- Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection
- Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
- Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
- GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist Cycles
- Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer
- Bay98-7196, Dose Finding / POC Study
- Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
- Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
- Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
- The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes
- Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
- CA 125 and VAS Pain Score Changes to Diagnose Endometriosis
- Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation
- Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
- LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
- Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
- Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study
- Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients
- Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
- Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
- Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence
- Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
- Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
- Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
- The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
- Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
- Relationship Between the Menstrual Cycle and Heart Disease in Women
- Study of Dual Trigger Ovulation in Oocyte Donors
- Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
- Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
- Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
- hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF
- Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide
- Preservation of Ovarian Function After Hematopoietic Cell Transplant
- S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
- GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
- Neoadjuvant Ipilimumab in Prostate Cancer
- Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
- Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
- Influence of Male Hormones on Regional Fat Metabolism
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
- Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
- A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
- Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
- Post-operative or Early Salvage XRT and ADT for High Risk PCa
- Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
- Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
- Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer
- A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer
- Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
- Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
- Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
- Prevention of Obesity in Women Via Estradiol Regulation
- Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
- Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
- Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
- Study of Lupron Depot In The Treatment of Central Precocious Puberty
- Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer
- Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
- A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
- Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
- A Study of Leuprolide to Treat Prostate Cancer
- Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
- Comparison of Two Pharmacological Treatments of Pedophilia
- Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer
- Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
- Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
- Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS)
- Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
- Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
- Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)
- Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
- Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
- Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
- Understanding Experimentally Induced Hot Flushes
- Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
- GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
- Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
- PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
- The Use of GnRH Agonist Trigger in the Prevention of OHSS
- Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
- Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
- A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
- Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
- ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
- Medical Treatment of Endometriosis-Associated Pelvic Pain
- Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
- Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
- Lupron Sex Offender Therapy
- A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
- Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
- Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
- Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
- Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
- ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation
- Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
- S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
- Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
- Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
- Leuprolide in Determining the Cause of Gonadotropin Deficiency
- Purification of Testis-Stimulating Factor in Precocious Puberty
- Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
- Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
- Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
- Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
- The Effects of Reproductive Hormones on Mood and Behavior
- A Treatment Study for Premenstrual Syndrome (PMS)
Clinical trials list
click for details